AU6387401A - Pyrrole derivatives for treating aids - Google Patents
Pyrrole derivatives for treating aidsInfo
- Publication number
- AU6387401A AU6387401A AU6387401A AU6387401A AU6387401A AU 6387401 A AU6387401 A AU 6387401A AU 6387401 A AU6387401 A AU 6387401A AU 6387401 A AU6387401 A AU 6387401A AU 6387401 A AU6387401 A AU 6387401A
- Authority
- AU
- Australia
- Prior art keywords
- pyrrole derivatives
- treating aids
- aids
- pyrrole
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0016453.3A GB0016453D0 (en) | 2000-07-04 | 2000-07-04 | Pyrrole derivatives |
PCT/EP2001/004832 WO2002002524A1 (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6387401A true AU6387401A (en) | 2002-01-14 |
Family
ID=9895031
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001263874A Ceased AU2001263874B2 (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
AU6387401A Pending AU6387401A (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001263874A Ceased AU2001263874B2 (en) | 2000-07-04 | 2001-04-30 | Pyrrole derivatives for treating aids |
Country Status (17)
Country | Link |
---|---|
US (1) | US6737429B2 (en) |
EP (1) | EP1301481A1 (en) |
JP (1) | JP2004502674A (en) |
KR (1) | KR100549884B1 (en) |
CN (1) | CN1440385A (en) |
AR (1) | AR028602A1 (en) |
AU (2) | AU2001263874B2 (en) |
BR (1) | BR0112241A (en) |
CA (1) | CA2412270A1 (en) |
EC (1) | ECSP014109A (en) |
GB (1) | GB0016453D0 (en) |
GT (1) | GT200100111A (en) |
MX (1) | MXPA02012409A (en) |
PA (1) | PA8516201A1 (en) |
PE (1) | PE20020269A1 (en) |
UY (1) | UY26720A1 (en) |
WO (1) | WO2002002524A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1405849A1 (en) * | 2002-10-04 | 2004-04-07 | Corning Incorporated | Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom |
WO2005063293A1 (en) * | 2003-12-26 | 2005-07-14 | Masatoshi Hagiwara | Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient |
US8048909B2 (en) | 2004-09-30 | 2011-11-01 | Takeda Pharmaceutical Company Limited | Proton pump inhibitors |
TW200628446A (en) * | 2004-12-14 | 2006-08-16 | Takeda Pharmaceuticals Co | Substituted pyrrole derivative |
US20080176919A1 (en) * | 2005-01-06 | 2008-07-24 | Pfizer Inc | Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators |
ES2391757T3 (en) | 2005-08-30 | 2012-11-29 | Akeda Pharmaceutical Company Limited | 1-H-Pyrrole derivatives substituted with 1-heterocyclylsulfonyl, 2-aminomethyl, 5-heteroaryl as acid secretion inhibitors |
EP2076492A4 (en) * | 2006-10-06 | 2010-12-22 | Merck Sharp & Dohme | Non-nucleoside reverse transcriptase inhibitors |
CA2669675A1 (en) * | 2006-11-10 | 2008-05-15 | Syndax Pharmaceuticals, Inc. | Combination of er.alpha.+ ligands and histone deacetylase inhibitors for the treatment of cancer |
US8933105B2 (en) | 2007-02-28 | 2015-01-13 | Takeda Pharmaceutical Company Limited | Pyrrole compounds |
WO2009015180A2 (en) * | 2007-07-23 | 2009-01-29 | Syndax Pharmaceuticals, Inc. | Novel compounds and methods of using them |
EP2179329A1 (en) * | 2007-10-16 | 2010-04-28 | Nikon Corporation | Illumination optical system, exposure apparatus, and device manufacturing method |
US20090131367A1 (en) * | 2007-11-19 | 2009-05-21 | The Regents Of The University Of Colorado | Combinations of HDAC Inhibitors and Proteasome Inhibitors |
JO2871B1 (en) | 2008-08-27 | 2015-03-15 | تاكيدا فارماسوتيكال كمبني ليمتد | Pyrrole compounds |
GB0823001D0 (en) * | 2008-12-17 | 2009-01-28 | Syngenta Participations Ag | Thiophene,furan and pyrrole derivatives with plant growth regulating properties |
CN101775011B (en) * | 2009-01-13 | 2013-07-31 | 中国人民解放军军事医学科学院毒物药物研究所 | N-substituted phenyl-3-methylene heterocyclic arene-2,5-dimethylpyrrole compound and application thereof in anti-HIV/AIDS |
AU2020388636A1 (en) * | 2019-11-19 | 2022-05-26 | New York Blood Center, Inc. | Substituted heterocyclics with therapeutic activity in HIV |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3644631A (en) * | 1969-05-13 | 1972-02-22 | Endo Lab | Therapeutic methods utilizing aryl pyrrol-3-yl ketones |
US4282242A (en) * | 1980-03-07 | 1981-08-04 | Pfizer Inc. | Antidiabetic pyrrolecarboxylic acids |
US4347186A (en) * | 1980-10-20 | 1982-08-31 | Syntex (U.S.A.) Inc. | Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein |
ES2139676T3 (en) * | 1992-12-17 | 2000-02-16 | Pfizer | SUBSTITUTED PIRAZOLES AS CRF ANTAGONISTS. |
EP0764153A1 (en) * | 1994-06-06 | 1997-03-26 | Pfizer Inc. | Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
CA2260213C (en) * | 1996-07-11 | 2005-03-29 | Pfizer Inc. | Pyridylpyrrole compounds useful as interleukin- and tnf antagonists |
DE19963174A1 (en) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substituted pyrrole Mannich bases |
-
2000
- 2000-07-04 GB GBGB0016453.3A patent/GB0016453D0/en not_active Ceased
-
2001
- 2001-04-30 KR KR1020037000138A patent/KR100549884B1/en not_active IP Right Cessation
- 2001-04-30 WO PCT/EP2001/004832 patent/WO2002002524A1/en not_active Application Discontinuation
- 2001-04-30 AU AU2001263874A patent/AU2001263874B2/en not_active Ceased
- 2001-04-30 AU AU6387401A patent/AU6387401A/en active Pending
- 2001-04-30 EP EP01938137A patent/EP1301481A1/en not_active Withdrawn
- 2001-04-30 CA CA002412270A patent/CA2412270A1/en not_active Abandoned
- 2001-04-30 JP JP2002507781A patent/JP2004502674A/en active Pending
- 2001-04-30 MX MXPA02012409A patent/MXPA02012409A/en active IP Right Grant
- 2001-04-30 BR BR0112241-0A patent/BR0112241A/en not_active Withdrawn
- 2001-04-30 CN CN01812290A patent/CN1440385A/en active Pending
- 2001-05-04 PA PA20018516201A patent/PA8516201A1/en unknown
- 2001-05-18 UY UY26720A patent/UY26720A1/en not_active Application Discontinuation
- 2001-05-22 AR ARP010102414A patent/AR028602A1/en not_active Application Discontinuation
- 2001-05-25 PE PE2001000487A patent/PE20020269A1/en not_active Application Discontinuation
- 2001-06-12 GT GT200100111A patent/GT200100111A/en unknown
- 2001-06-13 US US09/880,534 patent/US6737429B2/en not_active Expired - Fee Related
- 2001-07-04 EC EC2001004109A patent/ECSP014109A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US6737429B2 (en) | 2004-05-18 |
BR0112241A (en) | 2003-06-24 |
MXPA02012409A (en) | 2003-04-25 |
CA2412270A1 (en) | 2002-01-10 |
GB0016453D0 (en) | 2000-08-23 |
EP1301481A1 (en) | 2003-04-16 |
ECSP014109A (en) | 2002-02-25 |
PE20020269A1 (en) | 2002-04-08 |
JP2004502674A (en) | 2004-01-29 |
CN1440385A (en) | 2003-09-03 |
KR20030014321A (en) | 2003-02-15 |
WO2002002524A1 (en) | 2002-01-10 |
US20020032221A1 (en) | 2002-03-14 |
AU2001263874B2 (en) | 2006-10-19 |
GT200100111A (en) | 2002-03-18 |
AR028602A1 (en) | 2003-05-14 |
UY26720A1 (en) | 2001-11-30 |
PA8516201A1 (en) | 2002-07-30 |
KR100549884B1 (en) | 2006-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182030A0 (en) | Cyanopyrrolidine derivatives | |
IL152783A0 (en) | 2-aminocarbonyl-9h-purine derivatives | |
HRP20030055A2 (en) | 4-phenyl-pyridine derivatives | |
IL150841A0 (en) | 1h-imidazopyridine derivatives | |
AU6387401A (en) | Pyrrole derivatives for treating aids | |
IL155103A0 (en) | Substituted c-cyclohexylmethylamine derivatives | |
AU4498201A (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain | |
IL155106A0 (en) | Substituted 1-aminobutan-3-ol derivatives | |
IL150557A0 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives | |
PL356565A1 (en) | Aminosulfonylbiphenyl derivatives | |
IL150558A0 (en) | Aminomethyl-phenyl-cyclohexanone derivatives | |
HK1046848A1 (en) | Specific therapeutic composition for treating aids | |
AU2163202A (en) | 5-amino-1-pentene-3-ol substituted derivatives | |
AU2069602A (en) | Process for preparing distamycin derivatives | |
AU7247801A (en) | Process for preparing distamycin derivatives | |
IL151598A0 (en) | 2-phenylpyran-4-one derivatives | |
GB0017852D0 (en) | Process for preparing distamycin derivatives | |
GB0009452D0 (en) | PTP1B-Inhibiting heterocyclic derivatives | |
GB0001993D0 (en) | Heterocyclic derivatives | |
GB0001972D0 (en) | Heterocyclic derivatives | |
GB0021639D0 (en) | Maurotoxin derivatives | |
HK1054937A1 (en) | 1-Methylcarbapenem derivatives |